Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2020

Open Access 01-12-2020 | Stroke | Case report

Late discovery of left atrial appendage occluder device embolization: a case report

Authors: Mohamad Jihad Mansour, Clément Bénic, Romain Didier, Antoine Noel, Martine Gilard, Jacques Mansourati

Published in: BMC Cardiovascular Disorders | Issue 1/2020

Login to get access

Abstract

Background

Left atrial appendage (LAA) closure has been well evaluated in the prevention of stroke in patients with atrial fibrillation. Device embolization remains one of the most common complications. To the best of our knowledge, there have been no reports of late discovery of LAA occluder device embolization at 1.5 years after implantation.

Case presentation

We describe the case of a 77-year-old man who underwent uneventful LAA closure. Echocardiography performed the next day showed the device in place. The patient was discharged but was then lost to follow-up. 1.5 years later, he was admitted for ischemic stroke. Transesophageal echocardiography showed the absence of the occluder device in the LAA. Computed tomography scan of the abdomen showed the device in the abdominal aorta. Due to the high cardiovascular risk, the device was kept in place and the patient was treated medically.

Conclusions

Per-procedural and late device embolization are not uncommon. Review of the literature however showed no report of late discovery of device embolization at 1.5 years. Follow-up echocardiography is mandatory for the detection of endothelialization or embolization.
Literature
1.
go back to reference Fountain RB, Holmes DR, Chandrasekaran K, Packer D, Asirvatham S, Van Tassel R, et al. The PROTECT AF (WATCHMAN left atrial appendage system for embolic PROTECTion in patients with atrial fibrillation) trial. Am Heart J. 2006 May;151(5):956–61.CrossRef Fountain RB, Holmes DR, Chandrasekaran K, Packer D, Asirvatham S, Van Tassel R, et al. The PROTECT AF (WATCHMAN left atrial appendage system for embolic PROTECTion in patients with atrial fibrillation) trial. Am Heart J. 2006 May;151(5):956–61.CrossRef
2.
go back to reference Holmes DR, Kar S, Price MJ, Whisenant B, Sievert H, Doshi SK, et al. Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol. 2014;64(1):1–12.CrossRef Holmes DR, Kar S, Price MJ, Whisenant B, Sievert H, Doshi SK, et al. Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol. 2014;64(1):1–12.CrossRef
3.
go back to reference Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet Lond Engl. 2009;374(9689):534–42.CrossRef Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet Lond Engl. 2009;374(9689):534–42.CrossRef
4.
go back to reference Sick PB, Schuler G, Hauptmann KE, Grube E, Yakubov S, Turi ZG, et al. Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation. J Am Coll Cardiol. 2007 Apr 3;49(13):1490–5.CrossRef Sick PB, Schuler G, Hauptmann KE, Grube E, Yakubov S, Turi ZG, et al. Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation. J Am Coll Cardiol. 2007 Apr 3;49(13):1490–5.CrossRef
5.
go back to reference Swaans MJ, Post MC, Rensing BJWM, Boersma LVA. Ablation for atrial fibrillation in combination with left atrial appendage closure: first results of a feasibility study. J Am Heart Assoc. 2012 Oct;1(5):e002212.CrossRef Swaans MJ, Post MC, Rensing BJWM, Boersma LVA. Ablation for atrial fibrillation in combination with left atrial appendage closure: first results of a feasibility study. J Am Heart Assoc. 2012 Oct;1(5):e002212.CrossRef
6.
go back to reference Reddy VY, Möbius-Winkler S, Miller MA, Neuzil P, Schuler G, Wiebe J, et al. Left atrial appendage closure with the watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix feasibility study with watchman left atrial appendage closure technology). J Am Coll Cardiol. 2013 Jun 25;61(25):2551–6.CrossRef Reddy VY, Möbius-Winkler S, Miller MA, Neuzil P, Schuler G, Wiebe J, et al. Left atrial appendage closure with the watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix feasibility study with watchman left atrial appendage closure technology). J Am Coll Cardiol. 2013 Jun 25;61(25):2551–6.CrossRef
7.
go back to reference Matsuo Y, Sandri M, Mangner N, Majunke N, Dähnert I, Schuler G, et al. Interventional closure of the left atrial appendage for stroke prevention. Circ J. 2014;78(3):619–24.CrossRef Matsuo Y, Sandri M, Mangner N, Majunke N, Dähnert I, Schuler G, et al. Interventional closure of the left atrial appendage for stroke prevention. Circ J. 2014;78(3):619–24.CrossRef
8.
go back to reference Pérez Matos AJ, Swaans MJ, Rensing BJWM, Heijmen RH, Mast EG, Boersma LVA, et al. Embolization of a left atrial appendage closure device unmasked by intermittent left bundle branch block. JACC Cardiovasc Interv. 2014;7(9):e115–7.CrossRef Pérez Matos AJ, Swaans MJ, Rensing BJWM, Heijmen RH, Mast EG, Boersma LVA, et al. Embolization of a left atrial appendage closure device unmasked by intermittent left bundle branch block. JACC Cardiovasc Interv. 2014;7(9):e115–7.CrossRef
10.
go back to reference Reddy VY, Gibson DN, Kar S, O’Neill W, Doshi SK, Horton RP, et al. Post-approval U.S. experience with left atrial appendage closure for stroke prevention in atrial fibrillation. J Am Coll Cardiol. 2017 Jan 24;69(3):253–61.CrossRef Reddy VY, Gibson DN, Kar S, O’Neill W, Doshi SK, Horton RP, et al. Post-approval U.S. experience with left atrial appendage closure for stroke prevention in atrial fibrillation. J Am Coll Cardiol. 2017 Jan 24;69(3):253–61.CrossRef
11.
go back to reference Boersma LVA, Schmidt B, Betts TR, Sievert H, Tamburino C, Teiger E, et al. Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry. Eur Heart J. 2016 Aug;37(31):2465–74.CrossRef Boersma LVA, Schmidt B, Betts TR, Sievert H, Tamburino C, Teiger E, et al. Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry. Eur Heart J. 2016 Aug;37(31):2465–74.CrossRef
12.
go back to reference Reddy VY, Sievert H, Halperin J, Doshi SK, Buchbinder M, Neuzil P, et al. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. JAMA. 2014 Nov 19;312(19):1988–98.CrossRef Reddy VY, Sievert H, Halperin J, Doshi SK, Buchbinder M, Neuzil P, et al. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. JAMA. 2014 Nov 19;312(19):1988–98.CrossRef
13.
go back to reference Pillarisetti J, Reddy YM, Gunda S, Swarup V, Lee R, Rasekh A, et al. Endocardial (watchman) vs epicardial (lariat) left atrial appendage exclusion devices: understanding the differences in the location and type of leaks and their clinical implications. Heart Rhythm. 2015 Jul;12(7):1501–7.CrossRef Pillarisetti J, Reddy YM, Gunda S, Swarup V, Lee R, Rasekh A, et al. Endocardial (watchman) vs epicardial (lariat) left atrial appendage exclusion devices: understanding the differences in the location and type of leaks and their clinical implications. Heart Rhythm. 2015 Jul;12(7):1501–7.CrossRef
14.
go back to reference Betts TR, Leo M, Panikker S, Kanagaratnam P, Koa-Wing M, Davies DW, et al. Percutaneous left atrial appendage occlusion using different technologies in the United Kingdom: a multicenter registry. Catheter Cardiovasc Interv Off J Soc Card Angiogr Interv. 2017;89(3):484–92.CrossRef Betts TR, Leo M, Panikker S, Kanagaratnam P, Koa-Wing M, Davies DW, et al. Percutaneous left atrial appendage occlusion using different technologies in the United Kingdom: a multicenter registry. Catheter Cardiovasc Interv Off J Soc Card Angiogr Interv. 2017;89(3):484–92.CrossRef
15.
go back to reference Saw J, Fahmy P, Azzalini L, Marquis J-F, Hibbert B, Morillo C, et al. Early Canadian multicenter experience with WATCHMAN for percutaneous left atrial appendage closure. J Cardiovasc Electrophysiol. 2017 Apr;28(4):396–401.CrossRef Saw J, Fahmy P, Azzalini L, Marquis J-F, Hibbert B, Morillo C, et al. Early Canadian multicenter experience with WATCHMAN for percutaneous left atrial appendage closure. J Cardiovasc Electrophysiol. 2017 Apr;28(4):396–401.CrossRef
16.
go back to reference Fanari Z, Goel S, Goldstein JA. Successful percutaneous retrieval of embolized transcatheter left atrial appendage closure device (watchman) using a modified vascular retrieval forceps. Cardiovasc Revasc Med. 2017;18(8):616-18. Fanari Z, Goel S, Goldstein JA. Successful percutaneous retrieval of embolized transcatheter left atrial appendage closure device (watchman) using a modified vascular retrieval forceps. Cardiovasc Revasc Med. 2017;18(8):616-18.
17.
go back to reference Gabriels J, Beldner S, Khan M, Zeitlin J, Jadonath R, Patel A. Embolization of watchman device following a hybrid radiofrequency ablation of atrial fibrillation and watchman implantation procedure. J Cardiovasc Electrophysiol. 2017 Jul;28(7):835–6.CrossRef Gabriels J, Beldner S, Khan M, Zeitlin J, Jadonath R, Patel A. Embolization of watchman device following a hybrid radiofrequency ablation of atrial fibrillation and watchman implantation procedure. J Cardiovasc Electrophysiol. 2017 Jul;28(7):835–6.CrossRef
18.
go back to reference Fastner C, Lehmann R, Behnes M, Sartorius B, Borggrefe M, Akin I. Veno-venous double lasso pull-and-push technique for transseptal retrieval of an embolized watchman occluder. Cardiovasc Revascularization Med Mol Interv. 2016;17(3):206–8.CrossRef Fastner C, Lehmann R, Behnes M, Sartorius B, Borggrefe M, Akin I. Veno-venous double lasso pull-and-push technique for transseptal retrieval of an embolized watchman occluder. Cardiovasc Revascularization Med Mol Interv. 2016;17(3):206–8.CrossRef
19.
go back to reference Deng H, Liao H, Liu Y, Chen S, Xue Y, Zhan X, et al. Acute heart failure caused by dislocation of a WATCHMAN left atrial appendage Occluder. JACC Cardiovasc Interv. 2016 May 23;9(10):e97–9.CrossRef Deng H, Liao H, Liu Y, Chen S, Xue Y, Zhan X, et al. Acute heart failure caused by dislocation of a WATCHMAN left atrial appendage Occluder. JACC Cardiovasc Interv. 2016 May 23;9(10):e97–9.CrossRef
20.
go back to reference Stöllberger C, Schneider B, Finsterer J. Serious complications from dislocation of a watchman left atrial appendage occluder. J Cardiovasc Electrophysiol. 2007 Aug;18(8):880–1.CrossRef Stöllberger C, Schneider B, Finsterer J. Serious complications from dislocation of a watchman left atrial appendage occluder. J Cardiovasc Electrophysiol. 2007 Aug;18(8):880–1.CrossRef
21.
go back to reference Barth C, Behnes M, Borgrefe M, Akin I. Peri-interventional embolization of left atrial appendage occlusion devices: two manoeuvers of successful retrieval. Eur Heart J Case Rep. 2018;2(1):yty001.PubMedPubMedCentral Barth C, Behnes M, Borgrefe M, Akin I. Peri-interventional embolization of left atrial appendage occlusion devices: two manoeuvers of successful retrieval. Eur Heart J Case Rep. 2018;2(1):yty001.PubMedPubMedCentral
22.
go back to reference Bösche LI, Afshari F, Schöne D, Ewers A, Mügge A, Gotzmann M. Initial experience with novel Oral anticoagulants during the first 45 days after left atrial appendage closure with the watchman device. Clin Cardiol. 2015 Dec;38(12):720–4.CrossRef Bösche LI, Afshari F, Schöne D, Ewers A, Mügge A, Gotzmann M. Initial experience with novel Oral anticoagulants during the first 45 days after left atrial appendage closure with the watchman device. Clin Cardiol. 2015 Dec;38(12):720–4.CrossRef
23.
go back to reference Obeid S, Nietlispach F, Luscher TF, Alibegovic J. Percutaneous retrieval of an endothelialized AMPLATZER cardiac plug from the abdominal aorta 6 months after embolization. Eur Heart J. 2014;35(47):3387.CrossRef Obeid S, Nietlispach F, Luscher TF, Alibegovic J. Percutaneous retrieval of an endothelialized AMPLATZER cardiac plug from the abdominal aorta 6 months after embolization. Eur Heart J. 2014;35(47):3387.CrossRef
24.
go back to reference Aminian A, Lalmand J, Tzikas A, Budts W, Benit E, Kefer J. Embolization of left atrial appendage closure devices: a systematic review of cases reported with the watchman device and the amplatzer cardiac plug. Catheter Cardiovasc Interv. 2015;86(1):128–35.CrossRef Aminian A, Lalmand J, Tzikas A, Budts W, Benit E, Kefer J. Embolization of left atrial appendage closure devices: a systematic review of cases reported with the watchman device and the amplatzer cardiac plug. Catheter Cardiovasc Interv. 2015;86(1):128–35.CrossRef
Metadata
Title
Late discovery of left atrial appendage occluder device embolization: a case report
Authors
Mohamad Jihad Mansour
Clément Bénic
Romain Didier
Antoine Noel
Martine Gilard
Jacques Mansourati
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2020
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-020-01589-9

Other articles of this Issue 1/2020

BMC Cardiovascular Disorders 1/2020 Go to the issue